Article

Real-time benefits verification assists practice management

pVerify's Vision Benefits API allows front-office staff to handle vision eligibility verifications seamlessly in their own EHR.

pVerify is adding real-time vision benefits verification to its list of solutions that combine technology with human-enabled AI to replace the manual processes of front-office staff, radically lowering labor costs while providing price transparency.

In the past, to verify a patient’s vision benefits required front-office staff to make phone calls and juggle passwords for individual websites, tasks often given to entry-level staff. pVerify's new Vision Benefits API allows VSP and EyeMed plans to be processed and returned in under 30 seconds, either in the pVerify Provider Portal or within company's EHR system through API Connection.

Real-time VSP and EyeMed Verification are included in the initial release; more vision payers, including Spectera, Davis and many others, will be added throughout the remainder of 2021.

"With the launch of our all-new Vision Benefits API, pVerify becomes the only company that offers real-time Medical, Dental and Vision verification APIs to the healthcare industry," said Jay Nitturkar, pVerify's CEO, in a statement.

According to the company, pVerify's HIPAA-complaint, SaaS offering includes fully-customizable eligibility portal, robust set of REST APIs, and mobile SDKs that power mission-critical, front-end eligibility process solutions for leading software companies as well as ambulatory practices in the healthcare sector.

The company also released a case study outlining how a 100+ location ophthalmology group solved complex billing issues and created price transparency while saving over $1.3 million in labor costs and navigating the fluctuation trends of IPAs in California.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
(Image credit: Ophthalmology Times) AGS 2025: Two-year data of bio-interventional cyclodialysis with scleral allograft with Leon W. Herndon Jr, MD
(Image credit: Ophthalmology Times) AGS 2025: Aqueous humor outflow improvement after excimer laser trabeculostomy with Clemens Strohmaier, PhD
(Image credit: Ophthalmology Times) AGS 2025: Long-term efficacy and safety of standalone and phaco ELT with Marc Toeteberg-Harms, MD
(Image credit: Ophthalmology Times) Thomas W. Samuelson, MD, shares clinical perspectives on DSLT, SLT, and glaucoma management
© 2025 MJH Life Sciences

All rights reserved.